You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

142 Results
Document
Jul 2025
Document
Jul 2025
Document
Jul 2025
Drug
Other Name(s): Reblozyl®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
amivantamab (Unfunded),
lazertinib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Guidelines and Advice
Status: Current
ID: GL 1-22-A
Version: 2
Jul 2022
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
letrozole,
ribociclib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2025
Drug
Other Name(s): Vitrakvi®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2025

Pages